ICGC Breast Cancer Project: Triple Negative/Lobular/Other United Kingdom (UK)
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: ICGC Breast Cancer Project: Triple Negative/Lobular/Other is a research collaboration whose article contributions are accrued to its participating partner institutions.
Partner Institutions
ICGC Breast Cancer Project: Triple Negative/Lobular/Other is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Academic Medical Center (AMC), UvA
- BC Cancer Agency (BCCA), PHSA
- Cancer Research UK (CRUK)
- Curie Institute
- Dana-Farber Cancer Institute (DFCI)
- Erasmus University Rotterdam (EUR)
- French National Cancer Institute (INCa)
- IRCCS National Cancer Institute (INT) Bari
- International Cancer Genome Consortium (ICGC)
- King's College London (KCL)
- Lund University (LU)
- Oslo University Hospital (OUS)
- Radboud University Nijmegen (RU)
- Singapore General Hospital (SGH)
- The Institute of Cancer Research (ICR)
- The University of Queensland (UQ)
- University of Tromsø - The Arctic University of Norway (UiT)
- Wellcome Sanger Institute